International Journal of
Medicine and Medical Sciences

  • Abbreviation: Int. J. Med. Med. Sci.
  • Language: English
  • ISSN: 2006-9723
  • DOI: 10.5897/IJMMS
  • Start Year: 2009
  • Published Articles: 537

Full Length Research Paper

Wuchereria bancrofti antigenaemia among school children: A case study of four communities in the Kassena-Nankana east district of the upper east region of Ghana

Abu Abudu
  • Abu Abudu
  • War Memmorial Hospital, Kassena/ Nankana East District Hospital, Navrongo, Ghana.
  • Search for this author on:
  • Google Scholar
Stephen Gbedemah
  • Stephen Gbedemah
  • Department of Pharmaceutics, Faculty of Pharmacy, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Search for this author on:
  • Google Scholar
David Dotse Wemegah
  • David Dotse Wemegah
  • Department of Physics, Faculty of Physical Sciences, College of Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Search for this author on:
  • Google Scholar
Sammy, C.K. Tay*
  • Sammy, C.K. Tay*
  • Department of Clinical Microbiology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Search for this author on:
  • Google Scholar


  •  Received: 16 December 2014
  •  Accepted: 02 March 2015
  •  Published: 27 March 2015

References

Alexander ND, Moyeed RA, Hyun PJ, Dimber ZB, Bockarie MJ, Stander J, Grenfell BT, Kazura JW, Alpers MP(2003). Spatial variation of Anopheles-transmitted Wucherariabancrofti and Plasmodium falciparum infection densities in Papua New Guinea. Filaria J. 2(1):14.
crossref
 
CDC (2010). Global Health Division of parasitic diseases and malaria.
 
Dunyo SK, Appawu M, Nkrumah FK, Baffoe-Wilmot A, Pedersen EM, Simonsen PE (1996). Lymphatic filariasis on the coast of Ghana. Trans. R. Soc. Trop. Med. Hyg. 90(6):634-8.
crossref
 
Dzodzomenyo M, Dunyo SK, Ahorlu CK, Coker WZ, Appawu MA, Pedersen EM, Simonsen PE (1999). Bancroftianfilariasis in an irrigation project community in southern Ghana. Trop. Med. Int. Health 4(1):13-8
crossref
 
Gbakima AA, Appawu MA, Dadzie S, Karikari C, Sackey SO, Baffoe-Wilmot A, Gyapong J, Scott AL (2005). Lymphatic filariasis in Ghana: establishing the potential for an urban cycle of transmission. Trop. Med. Int. Health 10(4):387-92.
crossref
 
Ghana Filariasis Elimination Programme (2008). Summary report for Centre for neglected Tropical Diseases, Liverpool, UK.
 
Global Programme to Eliminate Lymphatic Filariasis (2010). Halfway towards eliminating lymphatic filariasis. Progress report 2000-2009 and strategic plan 2010-2020.
 
Gyapong JO, Magnussen P,Binka FN (1994). Parasitological and clinical aspects of bancroftianfilariasis in Kassena- Nankana District, Upper East Region, Ghana. Trans. R. Soc. Trop. Med. Hyg. 88(5):555-557
crossref
 
Gyapong M, Gyapong JO, Adjei S and Weiss CVM (1996). Filariasis in northern Ghana: Some cultural beliefs and practices and their implications for disease control. Soc. Sci. Med. 43(2):235-242.
crossref
 
Harnett W, Bradley JE, Garate T (1998). Molecular and immunodiagnosis of human filarial nematode infections. Parasitology 117 Suppl:S59-71.
crossref
 
Menezes OA, Lins R, Norões J, Dreyer G, Lanfredi RM (2007). Comparative analysis of a chemotherapy effect on the cuticular surface of Wuchereriabancrofti adult worms in vivo. Parasitol. Res. 101(5):1311-1317.
crossref
 
Ngom P, Wontuo P, Wak G, Apaliya G, Nchor S, Nazzar A, Binka F, Macleod B, Phillips J (1999). The Navrongo Demographic Surveillance System: Report to the Rockefeller Foundation. Documentation Note Number 41.
 
Rocha A, Lima G, Medeiros Z, Santos A, Alves S, Montarroyos U, Oliveira P, Béliz F, Netto M, Furtado A (2009). Circulating filarial antigen (CFA) in the hydrocele fluid from individuals living in a bancroftianfilariasis area-Recife-Brasil, detected by the monoclo¬nal antibody Og4C3-assay. MemInst Oswaldo Cruz 99:101-105.
crossref
 
Swaminathan S, Perumal V, Adinarayanan S, Kaliannagounder K, Rengachari R, Purushothaman J (2012). Epidemiological Assessment of Eight Rounds of Mass Drug Administration for Lymphatic Filariasis in India: Implications for Monitoring and Evaluation. PLoS Negl. Trop. Dis. 6(11):e1926.
 
Tisch DJ, Bockarie MJ, Dimber Z, Kiniboro B, Taronga N, Hazlett FE, Kastens W, Alpers MP, Kazura JM (2008). Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: Changes in microfilareamia filarial antigen and Bm14 antibody after cessation. Am. J. Trop. Med. Hyg. 78(2):289-293.
Pubmed
 
Wayangankar S (2010). Filariasis. Medscape Reference Drugs Diseases and Procedures. Med. Hyg. 78(2):289-93.
 
WHO (1992). Expert Committee on Filariasis. Fifth Report. WHO Tech. Rep. Ser. 821. Geneva report of an informal meeting.
 
WHO (1998). World health report, Life in the 21st century. A vision for all, Report ofDirector General WHO.
 
WHO (2002). Global programme to eliminate lymphatic filariasis: Annual report onLymphaticfilariasis. Geneva: World Health Organization. MimeographedDocument WHO/CDS/CPE/CEE/2002.28.
 
WHO (2004). Weekly epidemiological record No. 40, 79, 357-3682004, 79, 357-368 No 40.
 
WHO (2005). Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at the implementation unit level. Geneva. Available at: http://whqlibdoc.who.int/hq/2005/who_cds_cpe_cee_2005.50.pdf
 
WHO (2009). Global programme to eliminate lymphatic filariasis: Wkly Epidermiol. Rec. 84(42):437-44.

 

Copyright © 2025 Author(s) retain the copyright of this article.

This article is published under the terms of the Creative Commons Attribution License 4.0

Back to Vol. 7 No. 3
Back to articles
SUBSCRIBE TO RSS
SUBMIT MANUSCRIPT
CONFERENCES